Top Stories
-
Diagnosed with stage 3 bladder cancer, Jeffrey Pulver underwent chemo, surgery, and a neobladder at Columbia—just in time to walk his daughter down the aisle, cancer-free, on their family farm.
-
Two teams at the Vagelos College of Physicians and Surgeons are working to train patients’ immune cells to seek and destroy rogue cells that cause cancer and autoimmune diseases.
Topic
-
Columbia cell therapy pioneer Michel Sadelain has received the 2025 Merkin Prize in Biomedical Technology and the 2025 King Faisal Prize in Medicine.
Topic
-
Columbia researchers are uncovering potential new therapies to counter the changing identities of cancer cells.
Topic
Latest News
- July 21, 2016
Adding a new drug called olaratumab to traditional chemotherapy increased survival in sarcoma patients, researchers at Columbia University Medical Center have found.
Topic
- July 15, 2016
The three-dimensional structure could help researchers develop novel therapies and diagnostic tools for diseases that are caused by a malfunction in calcium adsorption.
Topic
- July 12, 2016
According to a new report published in JAMA Oncology, women with BRCA1 mutations have a higher risk of developing an aggressive type of uterine cancer.
Topic
- July 8, 2016
$4 million grant gives Columbia, Weill Cornell Medicine, NewYork-Presbyterian, and NYC Health + Hospitals key role in precision medicine cohort program.
Topic
- July 1, 2016
CUMC, NYP, and Weill Cornell are participating in a care delivery model that supports and encourages higher quality, more coordinated cancer care.
Topic
- June 22, 2016
New research suggests that direct transmission of cancer among marine animals may be much more common than once thought.
Topic
- June 16, 2016
One out of four breast cancer patients skipped hormonal therapy if they previously avoided treating chronic conditions, Columbia researchers found.
Topic
